TITLE:
Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney Disease Subjects on Hemodialysis

CONDITION:
Kidney Failure, Chronic

INTERVENTION:
Zemplar

SUMMARY:

      To show non-inferiority in the incidence rates of elevated calcium-phosphorus product
      between two treatment groups: 1) a group having an initial dose based on baseline PTH
      (baseline iPTH/80) and 2) a group having a starting dose based on body weight (0.04 mcg/kg).
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 20 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Stage V Chronic Kidney Disease

          -  Patients on Hemodialysis requiring treatment for secondary hyperparathyroidism with
             vitamin D therapy
      
